Why Clinuvel, De Grey, and Advance NanoTek are soaring higher today

On a day that's seen another sea of red across the S&P/ASX 200 Index (INDEXASX:XJO), here are 3 ASX shares that are shining lights today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On a day that's seen another sea of red across the S&P/ASX 200 Index (INDEXASX: XJO), here are 3 ASX shares that are shining lights today.

a woman

Advance Nanotek Ltd (ASX: ANO)

The Advance Nanotek share price is trading 4.2% higher at the time of writing following an ASX announcement containing several updates yesterday afternoon.

Yesterday, the company reported it has started investigations into a possible capital reduction which may go ahead before the end of FY20. Additionally, in a profitability update, the company noted it recorded just over $1 million profit before tax for the month of February 2020. Along with this, the company added that its operations remain debt-free, and it has in excess of $1.9 million in the bank.

On top of these updates, the company also announced the signing of a new distribution agreement. Deveraux Specialties is to be Advance NanoTek's non-exclusive distributor for Canada. Advance Nanotek is aiming to grow its Canadian operations over the next year, as it has recently done in the US.

In addition, the company provided an update with regards to the potential impact of the coronavirus. Despite receiving 'concerning' feedback from its US distributor, Advance NanoTek believes its product will continue to experience demand.

Clinuvel Pharmaceuticals Limited (ASX: CUV)

The Clinuvel share price has surged higher today by 5.1% at the time of writing. Today's increase appears to be linked to an ASX release earlier in the week.

On Tuesday, Clinuvel announced it had secured a meeting with the US Food and Drug Administration (FDA) to progress the use of its drug, SCENESSE, for the treatment of vitiligo. The disease is a skin disorder characterised by the appearance of white to off-white skin patches in different parts of the body due to the loss of melanin production.

Pending ongoing safety and efficacy of its vitiligo program, Clinuvel will seek to file a supplemental New Drug Application for SCENESSE. The Clinuvel share price rocketed as much as 25% on the day of the announcement. After slightly dipping yesterday, this momentum appears to be pushing shares higher today.

De Grey Mining Limited (ASX: DEG)

The De Grey Mining share price is up by 3.04% today at the time of writing. Today's rise comes on the back of a massive 24.3% gain yesterday after the company announced results from drilling programs at the newly discovered Hemi Prospect. In early trade yesterday, De Grey Mining shares climbed as much as 44.44% higher.

According to yesterday's release, the company's recent drilling has revealed wide, continuous, and high-quality grade gold mineralisation. De Grey Mining believes this confirms a large-scale gold system at Hemi.

Additionally, the company believes that the significant sulphide zones beneath the high-grade gold zones are very encouraging, and the large sulphide zones have the potential to significantly increase Hemi's scale.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Advance NanoTek Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
Broker Notes

Buy, hold, sell: Life360, Northern Star, and Sigma shares

Are these popular shares buys? Here's how analysts rate them.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

6 ASX All Ords shares elevated to strong buy status after March sell-off

The ASX All Ords fell 8% in March after the US and Israel attacked Iran and oil and gas prices…

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Market News

Why Beetaloo, Fortescue, Orora, and Whitehaven Coal shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Man in a business suit leaps off a boulder in front of a blue sky.
Share Gainers

3 ASX 200 stocks surging 13% to 36% in this shortened trading week

Investors sent these three ASX 200 stocks flying higher following the Easter break. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Amaero, Mesoblast, Telix, and Tivan shares are charging higher today

These shares are ending the week on a high. But why?

Read more »

A young couple stands next to a real estate agent in an empty apartment they are inspecting.
Real Estate Shares

Mirvac shares sink to their lowest level since 2015. Is this ASX property giant back on the radar?

Multi-year lows put Mirvac shares back on investors’ watchlists today.

Read more »